Heart attack risk assessment company Cardio Diagnostics moves headquarters to Chicago

The company makes the Epi+Gen test that assesses the risk for the onset of new coronary heart disease.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news